S.B.
78
PHARMACY ACT AMENDMENTS
House Floor
Amendments
Amendment 4 March 13, 2013 11:57 AM
Representative Stewart E. Barlow
proposes the following amendments:
1. Page
17, Lines 510 through 516a
:
510
(8) S. (a) .S A pharmacist or pharmacy intern who substitutes an interchangeable
510a
biosimilar
511
product for a prescribed biological product shall:
512
S. [(a)] (i) .S notify the prescriber in writing S. , by fax, telephone, or electronic
512a1
transmission .S
512a
of the substitution, as soon as practicable, but not
513
later than three business days after dispensing the interchangeable biosimilar product in place
514
of the prescribed biological product; and
515
S. [(b)] (ii) .S include the name and manufacturer of the interchangeable biosimilar
515a
product
516
substituted.
516a
S. (b) This subsection is repealed on
{
March 31, 2016
}
May 15, 2015
. .S
2. Page
17a, Lines 521b through 521d
:
521b
63I-2-258. Repeal dates -- Title 58.
521c
(1) Subsection 58-72-201(1)(b) is repealed July 1, 2014.
521d
(2) Subsection 58-17b-606.5(8) is repealed on
{
March 31, 2016.
}
May 15, 2015.
.S
Page 1 of 1
LRGC
ajacobson
ajacobson